The European Society of Intensive Medicine (ESICM) recommends avoiding the use of albumin in neurosurgery, while the Scandinavian guidelines still recommend the use of albumin (20%) in patients with severe traumatic brain injury [15]. This evidence concerns the gene ALB and injury.